JP MORGAN/CALL/EDWARDS LIFESCIENCES/135/0.1/17.01.25

JP MORGAN/CALL/EDWARDS LIFESCIENCES/135/0.1/17.01.25 Share Price

DE000JL1J253

Real-time Bid/Ask 14:15:10 14/06/2024 BST
0.024 ^EUR / 0.12 ^EUR	+157.14%

Current month	-3.45%
1 month	-15.15%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart EDWARDS LIFESCIENCES CORPORATION

Chart JP MORGAN/CALL/EDWARDS LIFESCIENCES/135/0.1/17.01.25

Latest news about EDWARDS LIFESCIENCES CORPORATION

Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR	06-05	BU
Edwards Lifesciences Announces Results from Analysis of Data from Partner Trials Examining Outcomes of Transcatheter Aortic Valve Replacement Patients with Small Annulus	06-05	CI
Transcript : Edwards Lifesciences Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:30 AM	06-05
Transcript : Edwards Lifesciences Corporation Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 12:00 PM	06-04

More news

Quotes 5-day view

Date	Price	Change
14/06/24	0.025	-10.71%
13/06/24	0.028	+7.69%
12/06/24	0.026	+13.04%
11/06/24	0.023	-28.12%
10/06/24	0.032	+6.67%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 08:58 am

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	EDWARDS LIFESCIENCES CORPORATION
Issuer	J.P. Morgan
WKN	JL1J25
ISIN	DE000JL1J253
Date issued	06/04/2023
Strike	135 $
Maturity	17/01/2025 (217 Days)
Parity	10 : 1
Emission price	0.28 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	0.43 €
Lowest since issue	0.021 €
Delta	0x
Omega	0.000000
Premium	0x
Gearing	180.84x
Moneyness	1.033
Difference Strike	47.58 $
Difference Strike %	+35.25%
Spread	0.096 €
Spread %	80.00%
Intrinsic value	0.4114
Present value	-0.339365

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).

Sector

More about the company

Ratings for Edwards Lifesciences Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Consensus: Edwards Lifesciences Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

87.67 USD

Average target price

96.24 USD

Spread / Average Target

+9.77%

Consensus